Skip to main content

MOORE CAPITAL MANAGEMENT, LP

Position in PRME — Prime Medicine, Inc.

CIK 1448574 NEW YORK, NY

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,845,000
+$105,000 QoQ
Shares Held
500,000
0.0% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#34
of 186 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names. PRME ranks #22 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,845,000 500,000
2026-03-31 $1,740,000 500,000
2025-12-31 $1,735,000 500,000
2025-09-30 $2,770,000 500,000
2025-06-30 $1,235,000 500,000
2025-03-31 $995,000 500,000
2024-12-31 $1,460,000 500,000
2024-09-30 $1,935,000 500,000
2024-06-30 $2,570,000 500,000
2024-03-31 $3,500,000 500,000
2023-09-30 $4,261,832 446,733
2023-06-30 $6,544,638 446,733
2023-03-31 $6,150,000 500,000
2022-12-31 $9,290,000 500,000